You can learn more about the standards we follow in producing accurate, unbiased content in our editorial policy. multpl. “S&P 500 PE Ratio.” ...
Khaldoon Al Mubarak, CEO of Mubadala, discusses China's investment potential in the new Trump era. Judge issues nationwide injunction blocking Trump's bid to end birthright citizenship I grew up ...
(Bloomberg) -- Private credit has been the best-performing asset class for Mubadala Investment Co. for three years in a row, according to the Abu Dhabi sovereign wealth fund’s deputy group chief ...
Turkish fast grocery delivery company Getir and its largest shareholder, Mubadala, remain in disagreement over a restructuring plan that Abu Dhabi's state investment fund argues is crucial for ...
KELIX Bio, a subsidiary of Mubadala Investment Company, has completed its acquisition of DiabTec, a biomanufacturing facility previously owned by Julphar, one of the UAE’s largest pharmaceutical ...
RIYADH, Jan 19 (Reuters) - Turkish grocery delivery company Getir and its biggest shareholder, Abu Dhabi state investment fund Mubadala, remained at odds on Sunday over a restructuring plan which ...
The expectations placed upon Jalen Green have always been high. Since the Houston Rockets selected Green with the second overall pick of the 2021 NBA Draft, the shooting guard has proven he ...
Getir’s founding team had previously clashed with investors, primarily Mubadala, over the company’s strategy and costs. Its valuation plunged to $2.5 billion in 2023 from its peak of $11.8 ...
A founder of Turkish fast-delivery company Getir announced on Wednesday he would pursue legal action against what he called an "illegal coup" by Mubadala, the firm's largest shareholder, which was ...
KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar. This acquisition strengthens ...
UAE - Kelix bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar. This acquisition strengthens ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果